Preview
PathMaker Neurosystems, a clinical-stage ALS neurotechnology company, announced a peer-reviewed paper in Neuromodulation, the journal of the International Neuromodulation Society, reporting that its non-invasive Multi-Site DCS technology, which delivers…
The complete summary, “why it matters” analysis and the original source link are available to members.
NeuromodulationNeurostimulation